Antibacterial Agents TRIZ Cases

A kit identifies regulatory T cells using CD127 and CD25 markers for flow cytometry analysis.

Slow aerosol infusion reduces peak systemic exposure and off-target effects caused by concentrated bolus delivery methods.

Segmented heterocyclic compounds target necroptosis pathways to resolve specificity gaps in caspase-independent cell death treatment.

Linalool and alpha-terpineol formulations achieve one log bacterial reduction within one minute without causing eye irritation.

Modified tetracycline compounds inhibit cellular pathways to treat hematological cancers while reducing toxicity compared to traditional chemotherapy.

Bicyclic compounds inhibit Acetyl-CoA carboxylase to regulate fatty acid production and oxidation pathways.

Optimized sodium sulfate concentrations prevent viral aggregation during storage, preserving infectivity without requiring freeze-drying.

Hin47-HiD fusion protein serves as a carrier for polysaccharide antigens in conjugate vaccines.

A photosensitizing composition uses an oxygen carrier and surfactant to enhance penetration into dentinal tubules.

Phenyl ester side chains cleave in physiological fluid to generate free carboxylic acid groups.

Endolysin polypeptides penetrate Gardnerella vaginalis biofilms to lyse target bacteria, reducing infection recurrence without disrupting healthy vaginal flora.

Ex vivo priming of macrophages with inactive pathogens overcomes vaccine failure by inducing durable antigen-specific immune memory.

Tricyclic nitrogen compounds treat tuberculosis by modifying chemical structures to overcome limited efficacy against mammalian bacterial infections.

An anti-adrenomedullin antibody fragment stabilizes peptide levels to modulate bioactivity.

A phosphorothioate oligonucleotide binds to HMGB proteins to block immune activation pathways.

Engineered antibodies segment variable and constant domains to resolve the trade-off between neutralization potency and structural complexity.

High-loading zinc films reduce oral astringency while maintaining stability.

Glycomimetic BASA compounds inhibit selectin adhesion, reducing toxicity and improving ADME characteristics for inflammatory disease treatment.

Formula One pyrazole molecules overcome widespread pest resistance by varying substituents to maintain broad-spectrum efficacy.

A powder composition comprising lactic acid, lactose, and kaolin treats auditory canal disorders in mammals.

Benzoxazino-rifamycin compounds inhibit Mycobacterium tuberculosis RNA polymerase with reduced human pregnane X receptor activation.

IL-22 agonists modulate host immune responses to protect the intestinal epithelial barrier against attaching and effacing pathogens.

Pyrimidine compounds target bacterial gyrase with coumarin scaffolds to overcome antibiotic resistance.

Sulphate groups react with protein structures to increase membrane permeability, resolving the trade-off between biocidal efficacy and mammalian toxicity.

Specific inhibitor compounds bind zinc ions in the enzyme active site, restoring antibiotic efficacy against resistant bacteria.

Optimizing heat treatment temperature and duration reduces lipase activity in bacterins, preventing emulsion breakdown while preserving antigenic activity.

Ozonized olive oil with vegetable extracts inhibits pathogenic microbial growth while maintaining vaginal microenvironment balance.

A 1-monocaprin nail lacquer forms a flexible film to deliver antifungal agents through the nail plate.

Lactobacillus curvatus fermentation of rye bran produces anti-adherence substances that prevent bacterial colonization without inducing antibiotic resistance.

Targeted RIP1 kinase inhibitors address the lack of effective necrosis treatments by blocking necroptosis.

Ibudilast inhibits MIF to reduce immune suppression and enhance CD4+ T-cell counts in cancer patients.

Mutagenically-induced mutations reduce virulence while adjuvants enhance immunity against heterologous serotypes.

Polyamine compounds disrupt biofilm matrices to kill bacteria, overcoming antibiotic resistance.

Dissolving molecular oxygen in organopolysiloxanes creates a carrier solution that delivers gas directly to bacterial membranes.

Cyclized peptide SVHSFDYDWYNV overcomes bacterial resistance mechanisms by reducing minimum bactericidal concentrations.

Butyricicoccus pullicaecorum strains colonize the gut and produce butyric acid in situ.

Rheology structurants and surface energy modifiers in a lotion composition coat absorbent article topsheets to resist menstrual fluid fouling.

Liposomes encapsulate polymyxin B to enhance bioavailability in epithelial lining fluid, reducing nephrotoxicity.

Uridine mediates mitochondrial protection against nucleoside analogs to resolve the contradiction between enhanced antibacterial efficacy and cellular toxicity.

D-galactose binds AI-2 receptors to block bacterial communication, avoiding antibiotic resistance and toxicity.

Segmenting racemic ornidazole isolates the L-enantiomer, which lowers central nervous system toxicity while maintaining antibacterial efficacy.

N-halo amino acid compositions release halogen species to destroy microbes while minimizing cytotoxicity through in situ generation.

Formula I compounds modulate P2X7 receptors, addressing the lack of effective therapies for neuroinflammation.

A metered dose inhaler device vaporizes cannabis extracts at controlled temperatures to deliver active agents via the pulmonary route.

Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds inhibit the MDM2-p53 interaction.